Cheryl A. Jay
Impact in
- Virology top 5%
- HIV Research and Treatment
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
Papers in
-
- HIV/AIDS drug development and treatment 2
-
- Metabolism and Genetic Disorders 3
- Co-authors
- Donald I. Abrams (3 shared papers)Starley B. Shade (3 shared papers)Michael Eamon Kelly (2 shared papers)Michael C. Rowbotham (2 shared papers)Karin Lottrup Petersen (2 shared papers)Haatem M. Reda (2 shared papers)Neal L. Benowitz (1 shared paper)Marinos C. Dalakas (2 shared papers)
- Journals
- Neurology (4 papers)Acta Neuropathologica (2 papers)Annals of Neurology (2 papers)Current Treatment Options in Neurology (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Cheryl A. Jay
17 papers receiving 1.1k citations
Cheryl A. Jay's Hit Papers
Peers
Comparison fields: 5 of 88
- Virology 157
- Pharmacology 550
- Toxicology 66
- Clinical Biochemistry 108
- Emergency Medicine 136
Countries citing papers authored by Cheryl A. Jay
This map shows the geographic impact of Cheryl A. Jay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl A. Jay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl A. Jay more than expected).
Fields of papers citing papers by Cheryl A. Jay
This network shows the impact of papers produced by Cheryl A. Jay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl A. Jay. The network helps show where Cheryl A. Jay may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheryl A. Jay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cannabis in painful HIV-associated sensory neuropathy Hit paper breakdown → | 2007 | 470 |
| 2 | 2007 | 203 | |
| 3 | 2013 | 98 | |
| 4 | 1994 | 96 | |
| 5 | 1999 | 76 | |
| 6 | 1995 | 61 | |
| 7 | 1995 | 47 | |
| 8 | 2006 | 41 | |
| 9 | 2008 | 21 | |
| 10 | Cannabis in painful HIV-associated sensory neuropathy | 2007 | 17 |
| 11 | 2000 | 16 | |
| 12 | 2010 | 11 | |
| 13 | 1994 | 10 | |
| 14 | 1995 | 5 | |
| 15 | 2003 | 5 | |
| 16 | 2014 | 4 | |
| 17 | 2019 | 3 | |
| 18 | 2008 | 1 | |
| 19 | 2014 | 0 |
About Cheryl A. Jay
Cheryl A. Jay is a scholar working on Infectious Diseases, Clinical Biochemistry, Epidemiology, Virology and Pharmacology, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Cannabis and Cannabinoid Research (3 papers), Metabolism and Genetic Disorders (3 papers), Glycogen Storage Diseases and Myoclonus (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), HIV/AIDS drug development and treatment (2 papers), HIV Research and Treatment (2 papers) and Infectious Diseases and Tuberculosis (2 papers). The work is most often cited by research in Virology (157 citations), Pharmacology (550 citations), Toxicology (66 citations), Clinical Biochemistry (108 citations) and Emergency Medicine (136 citations). Cheryl A. Jay has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Donald I. Abrams, Starley B. Shade, Michael Eamon Kelly, Michael C. Rowbotham, Karin Lottrup Petersen, Haatem M. Reda, Neal L. Benowitz, Marinos C. Dalakas, Marta Leon‐Monzon and Isa M. Bernardini. Their work appears in journals such as Neurology, Acta Neuropathologica, Annals of Neurology, Current Treatment Options in Neurology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.